Skip to main content

Wohl, Fischer Study Long Ebola Symptoms Which May Help Explain Long COVID.

September 21, 2022

Survivors of the Ebola outbreak in 2014 report a wide range of lingering symptoms that include fatigue and muscle pain, as well as neurological issues. But not much has been known about the persistence and severity of the symptoms over time. Investigators from the Institute for Global Health & Infectious Diseases, David Wohl, MD, professor … Continued

Wahl Receives $3.2 Million to Study the Neurological Consequences of HIV Infection

September 7, 2022

Angela Wahl, PhD, a member of the Institute for Global Health & Infectious Diseases (IGHID), the International Center for the Advancement for Translational Science, and assistant professor in the division of infectious diseases has received a $3.2 million R01 award to study the role of microglia in HIV latency and persistence in the brain. Over … Continued

Bringing Global to North Carolina

August 29, 2022

In a hospital, ambulance or a remote village in sub-Saharan Africa, researchers are focused on improving pregnancy outcomes with access to high-quality obstetric ultrasound, when and where it’s needed. Each year some 300,000 women and 3 million babies worldwide die during childbirth or shortly thereafter, according to the World Health Organization, which recommends ultrasound for all pregnancies … Continued

UNC Receives $17 Million to Develop AI-Enabled Obstetric Ultrasound

August 22, 2022

UNC-Chapel Hill has received a $17 million grant from the Bill & Melinda Gates Foundation to continue groundbreaking work in artificial intelligence (AI)-enabled obstetric ultrasound. CHAPEL HILL, NC – The new award will support an interdisciplinary team from the UNC School of Medicine and Gillings School of Global Public Health, with collaborators in Zambia, Kenya, … Continued

Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda

August 13, 2022

In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of terrain that might make for a beautiful and strenuous weekend hike for visitors but not necessarily for the people who live there. Residents of this region … Continued

I AM IGHID: Joelle Howard

August 12, 2022

Regulatory Affairs (RA) plays a critical role throughout the grant lifecycle, ensuring protocol integrity in the development of drugs and vaccines on the path to human use. Joelle Howard, who goes by Jo, joined IGHID last June. She is one of three regulatory document specialists who work across departments, schools, and countries to maintain accurate … Continued

IGHID Investigators Discuss Projects As New Academic Year Begins

August 12, 2022

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be … Continued

Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

August 8, 2022

Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, PhD, associate professor … Continued

Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

August 8, 2022

Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that … Continued

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 1, 2022

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). “HIV infection … Continued

CDC renews five-year funding for vector-borne disease threats

July 25, 2022

The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, and … Continued

Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

June 24, 2022

Recently published in eBioMedicine, this study represents the work of the late Professor Steve Meshnick who served as mentor to Andreea Waltmann, a postdoctoral scholar with the Institute for Global Health & Infectious Diseases. Dr. Meshnick died August 5, 2020.  Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination … Continued

NIAID recognizes HPTN’s groundbreaking work in covid prevention tools

June 9, 2022

The 2022 HPTN Annual Meeting took place June 5-8 in Washington, D.C., bringing hundreds of worldwide researchers, collaborators, community representatives, and government health officials together to share updates and accomplishments and re-engage with each other as a community. HPTN Principal Investigators Myron Cohen, MD, director of the UNC Institute for Global Health & Infectious Diseases … Continued

Baric led center receives $65 million grant

June 8, 2022

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery (AViDD) Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19. The center builds upon and is … Continued

Effect of intimate partner violence on oral PrEP adherence among adolescent girls and young women

June 7, 2022

Intimate partner violence events may either impede or motivate PrEP adherence among African adolescent girls and young women, with age appearing to be an important consideration for IPV-related adherence interventions, according to IGHID researchers Lisa Hightow-Weidman, MD, MPH, professor of infectious diseases and principal investigator for the UNC Behavioral and Technology Lab, and Audrey Pettifor, … Continued